Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Chamber-specific transcriptional responses in atrial fibrillation
Catherine E. Lipovsky, Jesus Jimenez, Qiusha Guo, Gang Li, Tiankai Yin, Stephanie C. Hicks, Somya Bhatnagar, Kentaro Takahashi, David M. Zhang, Brittany D. Brumback, Uri Goldsztejn, Rangarajan D. Nadadur, Carlos Perez-Cervantes, Ivan P. Moskowitz, Shaopeng Liu, Bo Zhang, Stacey L. Rentschler
Catherine E. Lipovsky, Jesus Jimenez, Qiusha Guo, Gang Li, Tiankai Yin, Stephanie C. Hicks, Somya Bhatnagar, Kentaro Takahashi, David M. Zhang, Brittany D. Brumback, Uri Goldsztejn, Rangarajan D. Nadadur, Carlos Perez-Cervantes, Ivan P. Moskowitz, Shaopeng Liu, Bo Zhang, Stacey L. Rentschler
View: Text | PDF
Research Article Cardiology Development

Chamber-specific transcriptional responses in atrial fibrillation

  • Text
  • PDF
Abstract

Atrial fibrillation (AF) is the most common cardiac arrhythmia, yet the molecular signature of the vulnerable atrial substrate is not well understood. Here, we delineated a distinct transcriptional signature in right versus left atrial cardiomyocytes (CMs) at baseline and identified chamber-specific gene expression changes in patients with a history of AF in the setting of end-stage heart failure (AF+HF) that are not present in heart failure alone (HF). We observed that human left atrial (LA) CMs exhibited Notch pathway activation and increased ploidy in AF+HF but not in HF alone. Transient activation of Notch signaling within adult CMs in a murine genetic model is sufficient to increase ploidy in both atrial chambers. Notch activation within LA CMs generated a transcriptomic fingerprint resembling AF, with dysregulation of transcription factor and ion channel genes, including Pitx2, Tbx5, Kcnh2, Kcnq1, and Kcnip2. Notch activation also produced distinct cellular electrophysiologic responses in LA versus right atrial CMs, prolonging the action potential duration (APD) without altering the upstroke velocity in the left atrium and reducing the maximal upstroke velocity without altering the APD in the right atrium. Our results support a shared human/murine model of increased Notch pathway activity predisposing to AF.

Authors

Catherine E. Lipovsky, Jesus Jimenez, Qiusha Guo, Gang Li, Tiankai Yin, Stephanie C. Hicks, Somya Bhatnagar, Kentaro Takahashi, David M. Zhang, Brittany D. Brumback, Uri Goldsztejn, Rangarajan D. Nadadur, Carlos Perez-Cervantes, Ivan P. Moskowitz, Shaopeng Liu, Bo Zhang, Stacey L. Rentschler

×

Figure 4

Notch activation differentially regulates the transcriptome of the murine left versus right atrium.

Options: View larger image (or click on image) Download as PowerPoint
Notch activation differentially regulates the transcriptome of the murin...
Notch signaling was activated in adult CMs (iNICD) followed by RNA-sequencing of the RA and LA. (A) The number of significantly dysregulated transcripts in iNICD RA (orange) and LA (yellow) compared with littermate controls is shown, with Venn diagrams demonstrating primarily distinct transcriptional changes within RA and LA. (B) Gene ontology (GO) analysis on iNICD LA indicating the statistically significant Ingenuity Pathway Analysis–generated biological diseases that are either general or atrium-specific arrhythmia conditions from the top 25 disease categories and the key differentially expressed genes within the category. Red indicates downregulated, blue indicates upregulated, and color intensity is positively related to fold change. n = 6 control RA, n = 6 iNICD RA, n = 6 control LA, n = 6 iNICD LA. (C and D) Reverse transcription–quantitative polymerase chain reaction (RT-qPCR) validation of genes associated with cardiac electrophysiology and AF was performed on the LA of a second cohort of iNICD mice. K+ channel genes (C) and transcription factors (D) from the GO analysis that are associated with AF. n = 6 control LA, n = 6 iNICD LA. All fold changes are relative to Tbp. Data are presented as the mean from each group ± SEM. P < 0.05 was considered statistically significant. *P < 0.05; ***P < 0.001; ******P < 0.000001; ********P < 0.00000001; NS, not significant. Unpaired Student’s 2-tailed t test with a Welch’s correction was performed for all comparisons.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts